<?xml version="1.0" encoding="iso-8859-1"?>
<?xml-stylesheet type="text/xsl" href="rss.xsl"?>
<rss version="2.0">
  <channel>
          <title>Merck			
 - livepress.com</title>
      <link>http://Merck			
.livepress.com</link>
        <description>Updated every 15 minutes of every day - FOR PERSONAL USE ONLY</description>
    <language>en</language>
    <lastBuildDate/>
    <copyright>Copyright: (C) livepress.com</copyright>
    <docs/>
    <image>
      <title>livepress.com</title>
      <url>http://livepress.com/img/logo-live-press.gif</url>
      <link>http://livepress.com</link>
    </image>

    <item>
      <title><![CDATA[Merck not liable for man's health woes 
    (AP)
]]></title>
      <link>http://livepress.com/go/?132116</link>
      <source>YAHOO</source>
      <guid isPermaLink="false">http://livepress.com/go/?132116</guid>
      <pubDate>2006-08-02 18:53:41</pubDate>
      	<description><![CDATA[AP - A jury on Wednesday found pharmaceutical company  Merck  &amp; Co. not liable for causing an elderly man's heart ailments after he took the drug maker's once-popular painkiller Vioxx.]]></description>
            	<enclosure url="http://livepress.com/images/top-stories_132070.jpg"
                   type="image/jpg"
		   length="0"/>
          </item>
    <item>
      <title><![CDATA[Opening arguments begin in Vioxx trial 
    (AP)
]]></title>
      <link>http://livepress.com/go/?130843</link>
      <source>YAHOO</source>
      <guid isPermaLink="false">http://livepress.com/go/?130843</guid>
      <pubDate>2006-08-01 02:58:26</pubDate>
      	<description><![CDATA[    AP - The second federal plaintiff to claim that the painkiller Vioxx caused a heart attack was a fit retired FBI agent who watched his diet, exercised regularly and was a model patient, his lawyer says.  ]]></description>
            	<enclosure url="http://livepress.com/images/top-stories_132030.jpg"
                   type="image/jpg"
		   length="0"/>
          </item>
    <item>
      <title><![CDATA[Husband and Wife Legal Team Passionately Defend the Rights of Vioxx Plaintiffs]]></title>
      <link>http://livepress.com/go/?130087</link>
      <source>PRWeb</source>
      <guid isPermaLink="false">http://livepress.com/go/?130087</guid>
      <pubDate>2006-07-31 03:13:17</pubDate>
      	<description><![CDATA[   As time runs short for potential Vioxx plaintiffs to file claims against  Merck  &amp; Company, the drug&#8217;s manufacturer, a team of Houston attorneys work diligently on behalf of their clients and potential plaintiffs. 

                        

      ]]></description>
            	<enclosure url="http://livepress.com/images/top-stories_132005.jpg"
                   type="image/jpg"
		   length="0"/>
          </item>
    <item>
      <title><![CDATA[Merck doubles profits despite GlycoFi charge 
    (AFP)
]]></title>
      <link>http://livepress.com/go/?125819</link>
      <source>YAHOO</source>
      <guid isPermaLink="false">http://livepress.com/go/?125819</guid>
      <pubDate>2006-07-24 11:56:14</pubDate>
      	<description><![CDATA[    AFP - US pharmaceutical group  Merck  and Co announced a doubling of its quarterly net profits despite having to absorb a hefty charge related to its acquisition of biotech firm GlycoFi, Inc.  ]]></description>
            	<enclosure url="http://livepress.com/images/top-stories_131994.jpg"
                   type="image/jpg"
		   length="0"/>
          </item>
    <item>
      <title><![CDATA[Merck Doubles Quarterly Earnings]]></title>
      <link>http://livepress.com/go/?125813</link>
      <source>AHN</source>
      <guid isPermaLink="false">http://livepress.com/go/?125813</guid>
      <pubDate>2006-07-24 11:41:10</pubDate>
      	<description><![CDATA[On Monday, drugmaker  Merck  &amp; Co. Inc. raised its 2006 profit forecast and said that its quarterly earnings had doubled. The New Jersey based company stated that it earned $1.50 billion, or 69 cents per share, in the second quarter. In comparison, they made $721 million, or 33 cents per share,...]]></description>
            	<enclosure url="http://livepress.com/images/top-stories_132116.jpg"
                   type="image/jpg"
		   length="0"/>
          </item>
    <item>
      <title><![CDATA[Merck profit doubles, raises 2006 forecast 
    (Reuters)
]]></title>
      <link>http://livepress.com/go/?125685</link>
      <source>YAHOO</source>
      <guid isPermaLink="false">http://livepress.com/go/?125685</guid>
      <pubDate>2006-07-24 08:09:19</pubDate>
      	<description><![CDATA[    Reuters -  Merck  & Co.  on Monday said its 
second-quarter earnings more than doubled on growing demand for 
its drugs, blowing past Wall Street expectations, and raised 
its full-year profit forecast.  ]]></description>
            	<enclosure url="http://livepress.com/images/top-stories_132099.jpg"
                   type="image/jpg"
		   length="0"/>
          </item>
    <item>
      <title><![CDATA[Merck poised to rise as Street remains wary: report 
    (Reuters)
]]></title>
      <link>http://livepress.com/go/?125612</link>
      <source>YAHOO</source>
      <guid isPermaLink="false">http://livepress.com/go/?125612</guid>
      <pubDate>2006-07-24 05:37:34</pubDate>
      	<description><![CDATA[    Reuters -  Merck  & Co. Inc. , knocked low 
by the recall of its arthritis drug Vioxx, is poised to rise 
because Wall Street has failed to appreciate cost cutting and 
new products likely to generate bigger-than-expected sales, a 
report said.  ]]></description>
            	<enclosure url="http://livepress.com/images/top-stories_132098.jpg"
                   type="image/jpg"
		   length="0"/>
          </item>
    <item>
      <title><![CDATA[Merck poised to rise as Street remains wary: report 
    (Reuters)
]]></title>
      <link>http://livepress.com/go/?125554</link>
      <source>YAHOO</source>
      <guid isPermaLink="false">http://livepress.com/go/?125554</guid>
      <pubDate>2006-07-24 03:06:05</pubDate>
      	<description><![CDATA[Reuters -  Merck  & Co. Inc. , knocked low 
by the recall of its arthritis drug Vioxx, is poised to rise 
because Wall Street has failed to appreciate cost cutting and 
new products likely to generate bigger-than-expected sales, a 
report said.]]></description>
            	<enclosure url="http://livepress.com/images/top-stories_132087.jpg"
                   type="image/jpg"
		   length="0"/>
          </item>
    <item>
      <title><![CDATA[Lawmaker alleges FDA, Merck collaborated 
    (AP)
]]></title>
      <link>http://livepress.com/go/?123308</link>
      <source>YAHOO</source>
      <guid isPermaLink="false">http://livepress.com/go/?123308</guid>
      <pubDate>2006-07-20 02:05:51</pubDate>
      	<description><![CDATA[AP - A federal health official worked with drug maker  Merck  to discredit a government whistleblower who publicized safety risks associated with the painkiller Vioxx, a lawmaker alleged Wednesday in seeking an investigation.]]></description>
            	<enclosure url="http://livepress.com/images/top-stories_132063.jpg"
                   type="image/jpg"
		   length="0"/>
          </item>
    <item>
      <title><![CDATA[Jurors rule for Merck in N.J. Vioxx case 
    (AP)
]]></title>
      <link>http://livepress.com/go/?121070</link>
      <source>YAHOO</source>
      <guid isPermaLink="false">http://livepress.com/go/?121070</guid>
      <pubDate>2006-07-14 00:52:26</pubDate>
      	<description><![CDATA[    AP - Elaine Doherty was the typical patient to whom drug maker  Merck  &amp;amp; Co. marketed its former  blockbuster  painkiller Vioxx: a senior citizen with  arthritis  and other ailments common among older folks, including heart disease.  ]]></description>
            	<enclosure url="http://livepress.com/images/top-stories_132064.jpg"
                   type="image/jpg"
		   length="0"/>
          </item>
    <item>
      <title><![CDATA[NJ Jury Rules Vioxx Not Substantial Factor In Heart Attack Suit]]></title>
      <link>http://livepress.com/go/?120782</link>
      <source>AHN</source>
      <guid isPermaLink="false">http://livepress.com/go/?120782</guid>
      <pubDate>2006-07-13 16:16:14</pubDate>
      	<description><![CDATA[A jury on Thursday ruled  Merck  &amp; Co.'s withdrawn pain medicine Vioxx was not a substantial factor in the heart attack of Elaine Doherty, a 68-year-old New Jersey woman. The jury of five men and two women also decided that although  Merck  failed to warn the plaintiff Doherty about the heart...]]></description>
            	<enclosure url="http://livepress.com/images/top-stories_132049.jpg"
                   type="image/jpg"
		   length="0"/>
          </item>
    <item>
      <title><![CDATA[Merck wins latest Vioxx case]]></title>
      <link>http://livepress.com/go/?120747</link>
      <source>CNN</source>
      <guid isPermaLink="false">http://livepress.com/go/?120747</guid>
      <pubDate>2006-07-13 15:37:53</pubDate>
      	<description><![CDATA[Merck was found not liable in the seventh lawsuit over Vioxx, the arthritis painkiller that it pulled from the market because of heart attack risk, the company announced Thursday.]]></description>
            	<enclosure url="http://livepress.com/images/top-stories_132050.gif"
                   type="image/gif"
		   length="0"/>
          </item>
    <item>
      <title><![CDATA[Jury absolves Merck in N.J. Vioxx case 
    (AP)
]]></title>
      <link>http://livepress.com/go/?120746</link>
      <source>YAHOO</source>
      <guid isPermaLink="false">http://livepress.com/go/?120746</guid>
      <pubDate>2006-07-13 15:35:52</pubDate>
      	<description><![CDATA[    AP -  Merck  &amp;amp; Co. won a crucial legal victory on Thursday, when jurors decided that the drugmaker&#039;s Vioxx painkiller, now the subject of at least 16,000 product liability lawsuits, did not cause a 68-year-old woman&#039;s heart attack.  ]]></description>
            	<enclosure url="http://livepress.com/images/top-stories_132041.jpg"
                   type="image/jpg"
		   length="0"/>
          </item>
    <item>
      <title><![CDATA[NJ jury finds Vioxx not a major heart attack factor 
    (Reuters)
]]></title>
      <link>http://livepress.com/go/?120691</link>
      <source>YAHOO</source>
      <guid isPermaLink="false">http://livepress.com/go/?120691</guid>
      <pubDate>2006-07-13 14:45:05</pubDate>
      	<description><![CDATA[    Reuters - A jury on Thursday found 
 Merck  &amp; Co.&#039;s  withdrawn pain medicine Vioxx was not a 
substantial factor in the heart attack of a 68-year-old New 
Jersey woman.  ]]></description>
            	<enclosure url="http://livepress.com/images/top-stories_132040.jpg"
                   type="image/jpg"
		   length="0"/>
          </item>
    <item>
      <title><![CDATA[Deliberations start in 7th Vioxx trial 
    (AP)
]]></title>
      <link>http://livepress.com/go/?119819</link>
      <source>YAHOO</source>
      <guid isPermaLink="false">http://livepress.com/go/?119819</guid>
      <pubDate>2006-07-12 12:00:11</pubDate>
      	<description><![CDATA[    AP - Jurors in the seventh trial over withdrawn painkiller Vioxx began deliberating Wednesday morning over the plaintiff&#039;s claim that the former  Merck  &amp;amp; Co. drug caused her 2004 heart attack.  ]]></description>
            	<enclosure url="http://livepress.com/images/top-stories_132032.jpg"
                   type="image/jpg"
		   length="0"/>
          </item>
    <item>
      <title><![CDATA[Jury hears closing arguments in Vioxx case 
    (AP)
]]></title>
      <link>http://livepress.com/go/?119078</link>
      <source>YAHOO</source>
      <guid isPermaLink="false">http://livepress.com/go/?119078</guid>
      <pubDate>2006-07-11 13:00:14</pubDate>
      	<description><![CDATA[    AP - Severely clogged arteries, obesity and other factors caused a 68-year-old grandmother&#039;s heart attack &amp;#151; not her use of Vioxx, lawyers for the drug&#039;s maker told jurors during closing arguments Tuesday in New Jersey&#039;s latest case over the withdrawn painkiller.  ]]></description>
            	<enclosure url="http://livepress.com/images/top-stories_132031.jpg"
                   type="image/jpg"
		   length="0"/>
          </item>
    <item>
      <title><![CDATA[Drug cos. set sights on diabetes care 
    (AP)
]]></title>
      <link>http://livepress.com/go/?118239</link>
      <source>YAHOO</source>
      <guid isPermaLink="false">http://livepress.com/go/?118239</guid>
      <pubDate>2006-07-04 22:47:01</pubDate>
      	<description><![CDATA[AP - Drug companies are racing to capture the ballooning market in  diabetes  care.  Pfizer  Inc. plans to debut Exubera, its new inhaled insulin treatment, in July, and  Merck  &amp; Co., Novartis AG and  Eli Lilly  and Co. are awaiting FDA approval for new  diabetes  products that could generate hundreds of millions of dollars in sales.]]></description>
            	<enclosure url="http://livepress.com/images/top-stories_132026.jpg"
                   type="image/jpg"
		   length="0"/>
          </item>
    <item>
      <title><![CDATA[Drug cos. set sights on diabetes care 
    (AP)
]]></title>
      <link>http://livepress.com/go/?117992</link>
      <source>YAHOO</source>
      <guid isPermaLink="false">http://livepress.com/go/?117992</guid>
      <pubDate>2006-07-04 12:40:36</pubDate>
      	<description><![CDATA[AP - Drug companies are racing to capture the ballooning market in diabetes care.  Pfizer  Inc. plans to debut Exubra, its new inhaled insulin treatment, in July, and  Merck  &amp; Co., Novartis AG and Eli Lilly and Co. are awaiting FDA approval for new diabetes products that could generate hundreds of millions of dollars in sales.]]></description>
            	<enclosure url="http://livepress.com/images/top-stories_132025.jpg"
                   type="image/jpg"
		   length="0"/>
          </item>
    <item>
      <title><![CDATA[Teens should get cervical cancer vaccine: panel 
    (Reuters)
]]></title>
      <link>http://livepress.com/go/?115381</link>
      <source>YAHOO</source>
      <guid isPermaLink="false">http://livepress.com/go/?115381</guid>
      <pubDate>2006-06-29 12:15:26</pubDate>
      	<description><![CDATA[Reuters - All young girls age 11 and 12 should 
take  Merck  and Co.'s vaccine to prevent  cervical cancer , as 
should 13- to 26-years-olds if they have not received it 
already, U.S. advisers decided on Thursday.]]></description>
            	<enclosure url="http://livepress.com/images/top-stories_132024.jpg"
                   type="image/jpg"
		   length="0"/>
          </item>
    <item>
      <title><![CDATA[Study correction shows early Vioxx risks 
    (AP)
]]></title>
      <link>http://livepress.com/go/?113317</link>
      <source>YAHOO</source>
      <guid isPermaLink="false">http://livepress.com/go/?113317</guid>
      <pubDate>2006-06-26 20:37:52</pubDate>
      	<description><![CDATA[AP - A correction published Monday by a medical journal to a key study on withdrawn painkiller Vioxx reveals the risk of heart problems was elevated throughout the time people took the drug and did not develop only after 18 months of use as the drug's maker,  Merck  &amp; Co., has contended.]]></description>
            	<enclosure url="http://livepress.com/images/top-stories_132008.jpg"
                   type="image/jpg"
		   length="0"/>
          </item>
    <item>
      <title><![CDATA[Study correction shows early Vioxx risk 
    (AP)
]]></title>
      <link>http://livepress.com/go/?113057</link>
      <source>YAHOO</source>
      <guid isPermaLink="false">http://livepress.com/go/?113057</guid>
      <pubDate>2006-06-26 13:29:48</pubDate>
      	<description><![CDATA[AP - A correction published Monday to a key study on withdrawn painkiller Vioxx reveals the risk of heart problems was elevated throughout the time people were on the drug and did not develop only after 18 months of use as the drug's maker,  Merck  &amp; Co., has contended.]]></description>
            	<enclosure url="http://livepress.com/images/top-stories_131995.jpg"
                   type="image/jpg"
		   length="0"/>
          </item>
    <item>
      <title><![CDATA[Zocor and Zoloft Patents To Expire]]></title>
      <link>http://livepress.com/go/?111760</link>
      <source>AHN</source>
      <guid isPermaLink="false">http://livepress.com/go/?111760</guid>
      <pubDate>2006-06-23 17:02:50</pubDate>
      	<description><![CDATA[Zocor, a cholesterol-cutting drug from  Merck  and Zoloft, antidepressant from  Pfizer  are going off patent this month. Merck's patent for Zocor expires Friday while Zoloft loses patent protection on June 30.
                    
                
                
                    ]]></description>
            	<enclosure url="http://livepress.com/images/top-stories_131973.jpg"
                   type="image/jpg"
		   length="0"/>
          </item>
    <item>
      <title><![CDATA[FDA approves generic versions of Zocor 
    (AP)
]]></title>
      <link>http://livepress.com/go/?111667</link>
      <source>YAHOO</source>
      <guid isPermaLink="false">http://livepress.com/go/?111667</guid>
      <pubDate>2006-06-23 14:30:54</pubDate>
      	<description><![CDATA[AP - The first generic versions of Zocor, the widely used  cholesterol  drug made by  Merck  &amp; Co. Inc., received federal approval Friday.]]></description>
            	<enclosure url="http://livepress.com/images/top-stories_131968.jpg"
                   type="image/jpg"
		   length="0"/>
          </item>
    <item>
      <title><![CDATA[Merck KGaA drops Parkinson's drug after clinical trials fail 
    (AFP)
]]></title>
      <link>http://livepress.com/go/?111566</link>
      <source>YAHOO</source>
      <guid isPermaLink="false">http://livepress.com/go/?111566</guid>
      <pubDate>2006-06-23 11:13:39</pubDate>
      	<description><![CDATA[    AFP -  Merck  KGaA -- the German drug maker that lost a takeover battle for Schering -- has said it is binning Saritozan, the drug it was developing to treat Parkinson&#039;s disease, after Phase III clinical trials failed.  ]]></description>
            	<enclosure url="http://livepress.com/images/top-stories_131962.jpg"
                   type="image/jpg"
		   length="0"/>
          </item>
    <item>
      <title><![CDATA[Merck KGaA drops Parkinson's drug after clinical trials fail 
    (AFP)
]]></title>
      <link>http://livepress.com/go/?111470</link>
      <source>YAHOO</source>
      <guid isPermaLink="false">http://livepress.com/go/?111470</guid>
      <pubDate>2006-06-23 08:26:58</pubDate>
      	<description><![CDATA[    AFP -  Merck  KGaA -- the German drug maker that lost a takeover battle for Schering -- has said it is binning Saritozan, the drug it was developing to treat Parkinson&#039;s disease, after Phase III clinical trials failed.  ]]></description>
            	<enclosure url="http://livepress.com/images/top-stories_131961.jpg"
                   type="image/jpg"
		   length="0"/>
          </item>
  </channel>
</rss>